JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M203248200 on May 6, 2002

J. Biol. Chem., Vol. 277, Issue 28, 25457-25464, July 12, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/28/25457    most recent
M203248200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marella, M.
Right arrow Articles by Chabry, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marella, M.
Right arrow Articles by Chabry, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Filipin Prevents Pathological Prion Protein Accumulation by Reducing Endocytosis and Inducing Cellular PrP Release*

Mathieu MarellaDagger , Sylvain Lehmann§, Jacques Grassi, and Joëlle ChabryDagger ||

From the Dagger  Institut de Pharmacologie Moléculaire et Cellulaire, Unité Mixte de Recherche 6097, Centre National de la Recherche Scientifique, 660 Route des Lucioles, 06560 Valbonne, France, the § Institut de Génétique Humaine, Centre National de la Recherche Scientifique, 34396 Montpellier, France, and the  Service de Pharmacologie et d'Immunologie, Commisariat à l'Energie Atomique, 91191 Gif-sur-Yvette, cedex, France

Conversion of the normal membrane-bound prion protein (PrP-sen) to its pathological isoform (PrP-res) is a key event in the pathogenesis of transmissible spongiform encephalopathies. Although the subcellular sites of conversion are poorly characterized, several lines of evidence have suggested the involvement of membrane lipid rafts in the conversion process. Here we report that copper stimulates the endocytosis of PrP-sen via a caveolin-dependent pathway in both microglia and neuroblastoma cells. We show that the polyene antibiotic filipin both limits endocytosis of PrP-sen and dramatically reduces the amount of membrane-bound PrP-sen. This reduction results from a rapid and massive release of full matured PrP-sen into the culture medium. Finally, we demonstrate that filipin is a potent inhibitor of PrP-res formation into chronically infected neuroblastoma cells. Our results reinforce the role of rafts in PrP trafficking and raise the possibility that the release of PrP-sen from the plasma membrane decreases the amount of available substrate PrP-sen at the conversion sites.


* This work was supported in part by French government grants from the "Action Concertée Incitive" Jeunes Chercheurs (2000) and by the "Groupement d'Intèrêt Scientifique" Infections à Prions (2001).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: IPMC, CNRS, 660 Route des Lucioles, 06560 Valbonne, France. Tel.: 334-93-95-77-67; Fax: 334-93-95-77-08; E-mail: chabry@ipmc.cnrs.fr.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
R. Kumar, D. McClain, R. Young, and G. A. Carlson
Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells
J. Gen. Virol., June 1, 2008; 89(6): 1525 - 1532.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani
Physiology of the Prion Protein
Physiol Rev, April 1, 2008; 88(2): 673 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Campana, A. Caputo, D. Sarnataro, S. Paladino, S. Tivodar, and C. Zurzolo
Characterization of the Properties and Trafficking of an Anchorless Form of the Prion Protein
J. Biol. Chem., August 3, 2007; 282(31): 22747 - 22756.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
J. Kleine-Vehn, P. Dhonukshe, R. Swarup, M. Bennett, and J. Friml
Subcellular Trafficking of the Arabidopsis Auxin Influx Carrier AUX1 Uses a Novel Pathway Distinct from PIN1
PLANT CELL, November 1, 2006; 18(11): 3171 - 3181.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. Campana, D. Sarnataro, C. Fasano, P. Casanova, S. Paladino, and C. Zurzolo
Detergent-resistant membrane domains but not the proteasome are involved in the misfolding of a PrP mutant retained in the endoplasmic reticulum
J. Cell Sci., February 1, 2006; 119(3): 433 - 442.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
D. R. Taylor, N. T. Watt, W. S. S. Perera, and N. M. Hooper
Assigning functions to distinct regions of the N-terminus of the prion protein that are involved in its copper-stimulated, clathrin-dependent endocytosis
J. Cell Sci., November 1, 2005; 118(21): 5141 - 5153.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Bate, S. Reid, and A. Williams
Phospholipase A2 Inhibitors or Platelet-activating Factor Antagonists Prevent Prion Replication
J. Biol. Chem., August 27, 2004; 279(35): 36405 - 36411.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Bate, M. Salmona, L. Diomede, and A. Williams
Squalestatin Cures Prion-infected Neurons and Protects Against Prion Neurotoxicity
J. Biol. Chem., April 9, 2004; 279(15): 14983 - 14990.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. T. Parkin, N. T. Watt, A. J. Turner, and N. M. Hooper
Dual Mechanisms for Shedding of the Cellular Prion Protein
J. Biol. Chem., March 19, 2004; 279(12): 11170 - 11178.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. Daude, M. Marella, and J. Chabry
Specific inhibition of pathological prion protein accumulation by small interfering RNAs
J. Cell Sci., July 1, 2003; 116(13): 2775 - 2779.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
D. A Harris
Trafficking, turnover and membrane topology of PrP: Protein function in prion disease
Br. Med. Bull., June 1, 2003; 66(1): 71 - 85.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
D. Dormont
Approaches to prophylaxis and therapy: An investigation into prion disease diversity
Br. Med. Bull., June 1, 2003; 66(1): 281 - 292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nunziante, S. Gilch, and H. M. Schatzl
Essential Role of the Prion Protein N Terminus in Subcellular Trafficking and Half-life of Cellular Prion Protein
J. Biol. Chem., January 31, 2003; 278(6): 3726 - 3734.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Sukumaran, M. J. Quon, and N. V. Prasadarao
Escherichia coli K1 Internalization via Caveolae Requires Caveolin-1 and Protein Kinase Calpha Interaction in Human Brain Microvascular Endothelial Cells
J. Biol. Chem., December 20, 2002; 277(52): 50716 - 50724.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.